Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia

NCT00006493 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

HIV Infections
Hyperlipidemia

Interventions

DRUG: Rosiglitazone

Sponsor

National Center for Research Resources (NCRR)